Science based writing on longevity, cancer, nutrition, supplements, hormones and preventive care. Written by our doctors, researchers and coaches. Every article carries a named clinician and the date it was last reviewed.
Testosterone therapy suppresses fertility, and that is the objection worth taking seriously. The rest of the safety picture has improved, but it is more complicated than the headlines...
As of September 2026, longevity medicine was not listed as a recognised specialty, and no universally accepted clinic model exists. That is...
What actually works costs less, and is more familiar than what's being sold to you.
Your consult covers the clinical questions. This is the practical stuff that comes up once you're actually on it: drinking, travelling, and...
Losing weight fast takes muscle with it, unless you actively protect it. Protein and resistance training are how you do that.
Screen for Life is Singapore's national screening programme. It covers the essentials, and it is worth knowing where it stops.
hs-CRP measures low grade inflammation linked to risk of heart disease. Most standard panels leave it out.
VO2 max is how well your body uses oxygen when you push hard. It is closely linked to how long and how...
Biological age estimates how worn your body seems, not how long you have lived. It is a statistical guess built from biological...
The HPV vaccine lowers the risk of the infections behind most cervical cancer. The evidence for it is strong and it works...
Tumour markers are blood proteins, not cancer tests on their own. A raised result raises a question, not an answer.
Lp(a) is set by your genes and barely changes through life. Testing it once tells you something cholesterol cannot.
ApoB counts the particles that drive heart disease. It can tell you more about your risk than cholesterol alone.
Fatty liver affects roughly one in three adults. Most have no symptoms, and in Asian populations it appears at weights that look...
Once a year, every January, we publish what our own patient data shows. Prevalence across the markers we test, what changed for members who retested, and what we got wrong. The first edition lands January 2027.
What we published, what we read, and the one thing worth changing. Nothing to buy.